1. Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia;Athyros;J. Cardiovasc. Risk.,2002
2. Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia;Betteridge;Postgrad. Med. J.,1996
3. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study;Cattin;Clin. Ther.,1990
4. Absorption and disposition of 2-(4-(2,2-dichlorocyclopropyl) phenoxy)-2-methyl propanoic acid, Win 35,833, in rats, monkeys, and men;Davison;Drug Metab. Dispos.,1975
5. The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate;Ferry;Br. J. Clin. Pharmacol.,1989